Home › Prostate Cancer › NCT05155501
Clinical Trial of Approaches to Prostate Cancer Surgery
Clinical TrIAL of Approaches to Prostate cAncer suRgery
Who can join
Ages 40 to 80 · Men
Full eligibility criteria
Inclusion Criteria: * Male sex * Age ≥40 years or ≤80 years * Scheduled for radical prostatectomy for clinically localized prostate cancer * Able to read and speak English or Spanish * Willingness to sign informed consent and adhere to the study protocol Exclusion Criteria: * Prior major pelvic surgery or radiotherapy * Suspicion of N1 disease (i.e., any lymph node greater than 1cm in maximal diameter)
About the study
This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy.
The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
What is being tested
- Robot-assisted radical prostatectomy (RP) (procedure)
- Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP) (procedure)
Sponsor: Weill Medical College of Cornell University · Participants: 600 · Started: May 15, 2023
Contact the study team
- May Ting, MBS · Phone: 732-757-2448
- Xiaohong Jing, PhD · Phone: 212-746-4739
Official record on ClinicalTrials.gov — NCT05155501
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.